Mm. Sockrider et al., MEASURING CLINICAL STATUS IN CYSTIC-FIBROSIS - INTERNAL VALIDITY AND RELIABILITY OF A MODIFIED NIH SCORE, Pediatric pulmonology, 17(2), 1994, pp. 86-96
We examined measurement properties of the NIH Clinical Score for Cysti
c Fibrosis (CF) as an index of disease status. This score is being emp
loyed as a research tool for defining study populations and as an outc
ome measure, yet there are no published data on its reliability or how
its items contribute to the overall measure of disease status. Criter
ia for scoring some items in the original index lack specificity. In t
his study, we used a modified score to have more clearly specified cri
teria, while retaining the original weightings and structure. For 200
patients with CF in two centers, we analyzed the total NIH Score and i
ts subscores for internal consistency, interrater reliability, and fac
tor analysis. Internal consistency indicates how inter-related the ite
ms are. The pulmonary subscore and overall score had fairly high inter
nal consistency. However, the general subscore had low internal consis
tency, suggesting that the items are not measuring a single element of
disease status and should not be added. Factor analysis provides addi
tional information on the underlying structure and relationships among
items. Five factors (groups of items) were identified accounting for
85% of the consistent variance of 14 items. These factors were designa
ted by items accounting for most of their variance: general pulmonary,
weight, disability, psychosocial, and acute infiltrate. While inter-r
ater reliability for the overall index was high, individual items show
ed less agreement. The results indicate that most of the variability i
n the NIH Score is attributable to pulmonary items in the first factor
. The analyses suggest a new scoring structure for the NIH Score; the
general subscore items do not contribute to the reliability or account
for significant variance. Therefore, they will likely require further
refinement or be eliminated. (C) 1994 Wiley-Liss, Inc.